Objective-To study the role ofrespiratory viruses in exacerbations ofasthma in adults. Design Conclusions-These findings show that asthma symptoms and reductions in peak flow are often associated with colds and respiratory viruses; respiratory virus infections commonly cause or are associated with exacerbations ofasthma in adults.
Introduction
Research into the effects of respiratory viral infections in chronic lung disease has been hampered by difficulties in identifying respiratory pathogens. Human rhinoviruses, the major causative agents of the common cold, are fastidious for certain cells and growth conditions, and the large numbers ofrecognised serotypes-in excess of 1 00-precludes serology for epidemiological studies. Human respiratory coronaviruses, which are second in importance in causing colds in adults, are also fastidious and serological tests are not widely available. Accordingly, rates of virus identification during acute respiratory infections have remained low, especially in adults. Two comparable prospective studies of asthmatic patients identified viruses in 55% of symptomatic respiratory tract infections in children under 11 years of age' but in only 26% of such infections in subjects aged years .2 Studies in children with asthma or wheezy bronchitis have shown that 38-49% of wheezy episodes are associated with respiratory viruses," but in adults virus and mycoplasma infections were identified in only 19%,6 and virus identification rates were 10% in two further studies.78 However, the percentage of laboratory confirmed viral infections that resulted in exacerbations of asthma was similar in the one study of adults with asthma (60%)8 to those reported for children (48-53%). 24 The weak association between asthma and upper respiratory tract infection suggested by previous epidemiological studies of adult asthmatics could have been due to difficulties in isolating human rhinoviruses and human coronaviruses.
We have used enzyme linked immunosorbent assays (ELISAs) for antibodies to human coronaviruses of groups 229E and OC43 in previous studies."' Evidence of human coronavirus infection was obtained in 7-19% of paired serum samples from patients with upper respiratory tract infections. In addition, we found seminested reverse transcriptase polymerase chain reactions to be five times more sensitive than cell culture in detecting human rhinoviruses in samples from adults with respiratory virus infections." Accordingly we thought that applying these diagnostic methods to clinical samples from adult asthma patients with symptoms of colds or asthma would lead to a better appreciation of the role of viruses in asthma in adults.
Methods

PATIENTS
We studied 138 adults with asthma, defined as recurrent episodes of reversible wheezing and breathlessness.'2 There were 48 men and 90 women 19-46 years of age (mean age 32-7 years) and their mid-morning mean peak expiratory flow rate on recruitment was 94-6% predicted (range 37 4-134 3%; SD 19-1%). The mean duration of wheeze was (1-43; 11-7) years. A total of 103 (75%) subjects were taking regular treatment with bronchodilators; 123 (89%) gave a history of eczema, hay fever, allergic rhinitis, nasal polyps, or allergies; and 53 (38%) had been admitted to hospital for an asthmatic attack.
Thirteen (9%/6) were smokers. Thirteen patients were recruited through the pulmonary function laboratory and chest physicians; 22 through an allergy clinic; 44 through general practitioners with age, sex, and disease registers; 49 made telephone requests to the trialists after seeing a newspaper article about the study; and 10 responded to posters advertising the study. Volunteers gave written informed consent to the protocol which was approved by the Leicestershire Health Authority ethics committee.
THE STUDY
The study ran from October 1990 to August 1992 and there was rolling recruitment to and exit from the study. Subjects were asked about the duration and frequency of their asthma, medication, hospitalisation, and history of atopy; they were examined clinically; peak expiratory flow rates were measured three times with a mini-Wright peak flow meter; and a baseline blood sample and nose and throat swabs were collected for serology and virological testing. Thereafter the subjects kept a daily diary of peak expiratory flow rate, which was measured twice daily, immediately on before going to bed; the best of three measurements was recorded. Subjects were instructed to contact the trialists by telephone or answerphone immediately they developed symptoms of an acute upper respiratory tract infection or increased symptoms of chest tightness or wheezing or breathlessness, and to keep a daily diary of the symptoms printed on the reverse of the flow rate diary during symptomatic episodes. Clinical assessment of upper respiratory symptoms followed a modification of the Common Cold Unit's standard protocol.'013 Respiratory symptoms were scored as absent, mild, moderately severe, and severe (box). Details of antibiotic use, bronchodilator use, medical consultations, and hospital admissions were also recorded. Symptomatic patients were seen at home or at work as soon as possible after the onset of symptoms and underwent examination of the oropharynx, neck, and chest. Nose and throat swabs and an acute phase 10 ml blood sample were collected during this visit, and a convalescent 10 ml blood sample was collected approximately 21 days later. All subjects were seen routinely every three months; during these visits a 10 ml blood sample and nose and throat swabs were collected.
VIROLOGY
Nasal swabs were placed high in the anterior nares and throat swabs were passed firmly over the pharynx and tonsils. Swabs were immediately placed together in 2-5 ml of nutrient broth containing virus transport medium (10% fetal calf serum, penicillin, streptomycin, and amphotericin B) and were stored at -70°C, usually within several hours of collection and always within Discussion An association between acute respiratory infections and asthmatic attacks in adults has been noted by others and in our previous studies'717 but, as no large longitudinal studies in adults have focused on both asthmatic events and upper respiratory infections and used a range of diagnostic techniques, the particular importance of respiratory viruses in adult asthmatic attacks has escaped recognition.
We identified viruses in 57% of subjects with symptomatic colds by adding rhinovirus seminested reverse transcriptase polymerase chain reaction and coronavirus ELISA to more conventional means of diagnosis. This is similar to the diagnostic rates of 5 1O% and 59% for adults with colds in our previous studies which used polymerase chain reaction and coronavirus ELISA." The majority (64%) of viruses identified were rhinoviruses. Because tests based on the polymerase chain reaction are particularly susceptible to false positive results due to contamination, we were careful to identify any possible sources of contamination and used appropriate methods to eliminate them. This included the use of separate sets of pipettes for reagents, samples, and products; the use of aerosol resistant pipette tips; and carrying out the various stages in the tests in different areas of the laboratory. Transport medium controls included in every assay gave no products after extraction, reverse transcription, and amplification. Similarly, none of 61 nose and throat swabs taken at baseline or routinely gave a positive result. These observations confirm and extend our previous negative findings with coded specimens from healthy controls."
The subjects in this study were enrolled from the community (43%), general practice (32%), and hospital (25%), and it was our intention that the study population be representative of young adults with asthma in the general population. However, there were twice a many women as men, and 38% of the volunteers had been admitted to hospital with an asthma attack, indicating that the trial population was skewed with both more women and more subjects with a history of severe or unstable asthma than in the general asthmatic population. Our subjects were stable on recruitment, with a mean peak expiratory flow rate of 94-6% predicted. Laboratory confirmed respiratory infections were no more common in women than men and, importantly, 10 (37%) ofthe 27 objective exacerbations of asthma associated with laboratory confirmed infections occurred in men, suggesting that "severe" exacerbations related to infection are also no more common in women than in men. As the prior hospitalisation rate in the study subjects was greater than anticipated, we compared the hospitalisation rate for subjects with a laboratory confirmed infection and objective evidence of an exacerbation with the hospitalisation rate for subjects with the same decrease in peak expiratory flow rate but no pathogen identified. There was no difference in the two rates (data not shown). Thus, it seems unlikely that the subjects' high rate of prior hospitalisation biased the results with respect to the identification of viruses in exacerbations of asthma.
Our findings that 80% of subjective asthma exacerbations occurred with symptomatic colds and that 89% of symptomatic colds were associated with symptoms of asthma suggest that acute respiratory infections are as commonly linked to exacerbations in adults as they are in children.2-5 To examine this relation further we focused on the more severe episodes with objective evidence of an exacerbation-these episodes were associated with mean decreases in peak expiratory flow rate of about 100 I/min on days 2 and 3 and led 49% of patients to consult their general practitioner and 38% to use oral steroids. We identified non-bacterial pathogens, predominantly viruses, in 44% of these exacerbations, a rate similar to that of 36% found by Beasley et al in severe exacerbations in New Zealand, but considerably greater than the rate of 5% for episodes not identified as severe,8 and 1 0% and 19% for all exacerbations in two other studies.67 In our study, 24% of laboratory confirmed infections were associated with mean decreases in peak expiratory flow rate > 50 I/min through days 1 to 7; 48% had mean decreases of ¢ 25 I/min; and chest tightness, wheeze, and breathlessness were experienced during 72%, 65%, and 70%, respectively, of laboratory confirmed infections. Beasley et al found that 10 of 30 laboratory confirmed respiratory infections (all caused by viruses) were associated with a severe attack and that 18 (60%) were associated with exacerbations. 8 Our laboratory's diagnostic rate for viruses in colds and asthma exacerbations was much higher than previous studies (Beasley et al, for example, identified viruses in 17% of 182 episodes with clinical respiratory infection8) but was still not as high as might be expected on the basis of symptoms. This may be due to several factors-virus isolation rates seem to be lower in adults than in children,'2 possibly owing to decreased virus shedding; the specimens from swabs in our study were not tested for viral antigens by immunofluorescence or enzyme immunoassay; and we used complement fixation tests for pathogens other than rhinoviruses and coronaviruses. Despite these limitations our tests linked influenza, respiratory syncytial virus, parainfluenza, and Chlamydia sp to the more severe exacerbations of asthma, and we speculate that more sensitive tests will find these and other non-bacterial pathogens to have a much greater role than our results suggest. Conceivably these agents were involved in the objective asthma episodes for which no pathogens were identified despite there being symptoms of a cold.
In evaluating the results of this and previous studies in adults, consideration must be given to the subjects and study design. Hudgel et al and Beasley et al recruited all their patients from hospital outpatient departments and an allergy clinic, raising the possibility that the airways disease was more severe or less stable than in our subjects.78 Huhti et al studied only patients admitted to hospital during an exacerbation.6 Thus of all the studies carried out to date ours is the most representative of young adults with asthma in the general population.
Respiratory viral infections often impair small airways function for several weeks in otherwise normal subjects; these abnormalities are not detected by routine spirometry.'"2' We reasoned that some asthmatic patients with acute respiratory infections might have modest decreases in breathing capacity lasting several weeks and rarely coming to medical attention. Thus rather than focus on a single abnormality in pulmonary function to define an exacerbation, BMJ VOLUME 307
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None of the previous studies in adults tested for coronaviruses, and Huhti et al did not culture for rhinoviruses. Fifty one questionnaires were returned by the female doctors. Forty seven felt comfortable examining without a chaperone. Their comments generally suggested that they had never thought it necessary to have a chaperone present; some said that it had never crossed their minds.
In all, 181 questionnaires were returned by the male doctors, the mean age of whom was 42-8 years. Ninety eight worked in rural practices. Only two doctors did not have a practice nurse available. Many used a chaperone with young patients. Other reasons for use included fear of litigation (41), the doctor's knowledge of the patient (13), and intuition (22) . The main reasons given for not using a chaperone were too time consuming, impractical, unnecessary, and not beneficial to the doctor-patient relationship. Sixty six thought that the use of a chaperone could damage the doctor-patient relationship, while 80 thought the opposite. Thirty one male doctors felt uncomfortable and 129 felt comfortable without a chaperone. We found no correlation between the frequency of use of chaperones and the practice size or doctor's age.
Male doctors mostly used practice nurses (135) as chaperones, but some also used receptionists (40), dispensers (one), and practice managers (two). (13) 
